紫元元(08223.HK)訂立售後回租協議
格隆匯1月8日丨紫元元(08223.HK)發佈公吿,董事會近日收到承租人(公司全資附屬公司)通知,承租人與出租人已於2022年12月27日訂立第四批售後回租協議,據此承租人同意按第四批轉讓款人民幣4773萬元將租賃資產的法定所有權轉讓予出租人,且出租人同意於第四批租賃期內將租賃資產回租給承租人。
在第四批租賃期屆滿並在承租人全額支付所有租賃付款和其他應付款項並履行第四批售後回租協議項下的其他義務的前提下,出租人應以名義金額人民幣1元將租賃資產的法定所有權讓回予承租人。租賃資產指售後回租協議項下位於中國的若干口腔醫療設備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.